Cargando…
AMP-independent activator of AMPK for treatment of mitochondrial disorders
Mitochondrial diseases are a clinically heterogenous group of disorders caused by respiratory chain dysfunction and associated with progressive, multi-systemic phenotype. There is no effective treatment or cure, and no FDA-approved drug for treating mitochondrial disease. To identify and characteriz...
Autores principales: | Moore, Tereza, Yanes, Rolando E., Calton, Melissa A., Vollrath, Douglas, Enns, Gregory M., Cowan, Tina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556449/ https://www.ncbi.nlm.nih.gov/pubmed/33052980 http://dx.doi.org/10.1371/journal.pone.0240517 |
Ejemplares similares
-
Depletion of Mitochondrial DNA in Differentiated Retinal Pigment Epithelial Cells
por: Hu, Xinqian, et al.
Publicado: (2019) -
Glutathione as a Redox Biomarker in Mitochondrial Disease—Implications for Therapy
por: Enns, Gregory M., et al.
Publicado: (2017) -
Degree of Glutathione Deficiency and Redox Imbalance Depend on Subtype of Mitochondrial Disease and Clinical Status
por: Enns, Gregory M., et al.
Publicado: (2014) -
Evidence of redox imbalance in a patient with succinic semialdehyde dehydrogenase deficiency
por: Niemi, Anna-Kaisa, et al.
Publicado: (2014) -
Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms
por: Chen, Suet Ching, et al.
Publicado: (2017)